{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:44:53Z","timestamp":1762004693847,"version":"3.40.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["P30 CA006973"],"award-info":[{"award-number":["P30 CA006973"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2011-0029348"],"award-info":[{"award-number":["2011-0029348"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.urology.2015.02.014","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T01:30:11Z","timestamp":1430098211000},"page":"1111-1116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study"],"prefix":"10.1016","volume":"85","author":[{"given":"Yejin","family":"Mok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heejin","family":"Kimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2174-4247","authenticated-orcid":false,"given":"Sang Yop","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9519-3068","authenticated-orcid":false,"given":"Sun Ha","family":"Jee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Platz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2015.02.014_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2015.02.014_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2013.45.1.1","article-title":"Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010","volume":"45","author":"Jung","year":"2013","journal-title":"Cancer Res Treat"},{"volume":"vol. 2014","year":"2012","key":"10.1016\/j.urology.2015.02.014_bib3"},{"key":"10.1016\/j.urology.2015.02.014_bib4","first-page":"419","article-title":"Early detection of prostate cancer: AUA guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.02.014_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10552-007-9083-8","article-title":"Quantifying the role of PSA screening in the US prostate cancer mortality decline","volume":"19","author":"Etzioni","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urology.2015.02.014_bib6","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2015.02.014_bib7","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/j.ejca.2010.09.013","article-title":"Prostate cancer incidence and mortality trends in 37 European countries: an overview","volume":"46","author":"Bray","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2015.02.014_bib8","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2015.02.014_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.1995.03520280035036","article-title":"A\u00a0prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer","volume":"273","author":"Gann","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2015.02.014_bib10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2011.11.007","article-title":"Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population","volume":"61","author":"Orsted","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2015.02.014_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1055-9965.EPI-07-0515","article-title":"Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation","volume":"17","author":"Connolly","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2015.02.014_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrurol.2014.42","article-title":"Prostate cancer in Asian men","volume":"11","author":"Ito","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2015.02.014_bib13","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1177\/2047487313497602","article-title":"The Korean Heart Study: rationale, objectives, protocol, and preliminary results for a new prospective cohort study of 430,920 men and women","volume":"21","author":"Jee","year":"2013","journal-title":"Eur J Prev Cardiol"},{"volume":"vol. 2014","year":"2014","key":"10.1016\/j.urology.2015.02.014_bib14"},{"key":"10.1016\/j.urology.2015.02.014_bib15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.urology.2015.02.014_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Amer Stat Assoc"},{"key":"10.1016\/j.urology.2015.02.014_bib17","first-page":"2031","article-title":"Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves","volume":"152","author":"Catalona","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.02.014_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.amepre.2013.04.015","article-title":"Prostate-specific antigen and prostate cancer mortality: a systematic review","volume":"45","author":"Wallner","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.urology.2015.02.014_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0090-4295(01)01304-8","article-title":"Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging","volume":"58","author":"Fang","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2015.02.014_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3322\/caac.20026","article-title":"Screening for prostate cancer","volume":"59","author":"Brawley","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2015.02.014_bib21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2015.02.014_bib22","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2015.02.014_bib23","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.2014.2085","article-title":"Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence","volume":"311","author":"Hayes","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2015.02.014_bib24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","article-title":"Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges","volume":"270","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2015.02.014_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0094-0143(21)00915-0","article-title":"PSA in benign prostatic hyperplasia and prostatic intraepithelial neoplasia","volume":"20","author":"Ellis","year":"1993","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2015.02.014_bib26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1200\/JCO.2010.31.2330","article-title":"Impact of comorbidity on survival among men with localized prostate cancer","volume":"29","author":"Albertsen","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2015.02.014_bib27","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1158\/1055-9965.EPI-05-0206","article-title":"Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002","volume":"14","author":"Saraiya","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2015.02.014_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrc2351","article-title":"Prostate-specific antigen and prostate cancer: prediction, detection and monitoring","volume":"8","author":"Lilja","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urology.2015.02.014_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jnci\/djh111","article-title":"Prostate-specific antigen and all-cause mortality: results from the Baltimore Longitudinal Study on Aging","volume":"96","author":"Carter","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2015.02.014_bib30","unstructured":"GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in\u00a02012."}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T03:40:06Z","timestamp":1651808406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429515001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0090429515001399"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2015.02.014","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2015.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}